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SUMMARY: Inhibitors of tumor growth using extracts from aromatic plants are rapidly emerging as important 
new drug candidates for cancer therapy. The cytotoxicity and in vitro anticancer evaluation of the essential oils 
from thyme, juniper and clove has been assessed against five different human cancer cell lines (liver HepG2, 
breast MCF-7, prostate PC3, colon HCT116 and lung A549). A GC/MS analysis revealed that α-pinene,  thymol 
and eugenol are the major components of Egyptian juniper, thyme and clove oils with concentrations of 31.19%, 
79.15% and 82.71%, respectively. Strong antioxidant profiles of all the oils are revealed in vitro by DPPH and 
β-carotene bleaching assays. The results showed that clove oil was similarly potent to the reference drug, doxo-
rubicin in prostate, colon and lung cell lines. Thyme oil was more effective than the doxorubicin in breast and 
lung cell lines while juniper oil was more effective than the doxorubicin in all the tested cancer cell lines except 
prostate cancer. In conclusion, the essential oils from Egyptian aromatic plants can be used as good candidates 
for novel therapeutic strategies for cancer as they possess significant anticancer activity.
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RESUMEN: Aceites esenciales de plantas aromáticas egipcias como novedosos agentes anticancerígenos y antioxi-
dantes en líneas celulares de cáncer humano. Los inhibidores de crecimiento de tumores usando extractos de 
plantas aromáticas están emergiendo con rapidez como nuevos e importantes medicamentos para el tratamiento 
del cáncer. La citotoxicidad y la acción anticancerígena in vitro de aceites esenciales de tomillo, enebro y clavo 
han sido evaluadas en cinco líneas celulares de cáncer humano (hígado HepG2, mama MCF-7, próstata PC3, 
colon HCT116 y pulmón A549). Los análisis de GC/MS mostraron que α-pineno, timol y eugenol son los prin-
cipales componentes de los aceites egipcios de enebro, tomillo y clavo, con concentraciones de 31,19%, 79,15% y 
82,71%, respectivamente. Se demuestra, mediante ensayos in vitro de blanqueo de DPPH y β-caroteno, el enérgico 
perfil antioxidante de todos los aceites. Los resultados mostraron que el aceite de clavo fue similar de potente al 
fármaco de referencia, doxorrubicina en las líneas celulares de próstata, colon y pulmón. El aceite de tomillo fue 
más efectivo que la doxorrubicina en las líneas celulares de mama y de pulmón, mientras que el aceite de enebro 
fue más eficaz que la doxorrubicina en todas las líneas celulares de cáncer ensayados, excepto en la de cáncer de 
próstata. En conclusión, los aceites esenciales de plantas aromáticas egipcias se pueden utilizar como buenos can-
didatos para nuevas estrategias terapéuticas para el cáncer al poseer una significativa actividad anticancerígena
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1. INTRODUCTION
Throughout history, natural products have 
afforded a rich repository of remedies with diverse 
chemical structures and bioactivities against sev-
eral heath disorders including cancer. The use of 
herbs as complementary and alternative medicine 
has increased dramatically in the last 20–25 years, 
herbs and spices have enjoyed a rich tradition of 
use for their flavor enhancement characteristics and 
for their medicinal properties. The search therefore 
continues to develop the drugs which selectively 
act on tumor cells without diverse side effects (Ali 
and Sohair, 2007). The screening of plant extracts/
essential oils and natural products for anti- oxidative 
activity has revealed the potential of higher plants 
as a source of new antioxidant agents. The oil 
could be an excellent alternative to a number of 
synthetic antioxidants such as butylated hydroxyl 
toluene (BHT), butylated hydroxyanisole (BHA) 
and tertiary butylhydroquinone (TBHQ), because 
there are concerns that these synthetic antioxidants 
may exhibit carcinogenic properties (Hamedo and 
Abdelmigid, 2009). Essential oil is a volatile, natu-
ral and complex compound present in a variety of 
aromatic plants and mostly extracted by steam or 
hydro-distillation from the plants (Jo et al., 2012). 
The rising prevalence of chronic diseases worldwide 
and the corresponding rise in health care costs is 
propelling interest among researchers and the pub-
lic due to the multiple health benefits related to these 
food items, including a reduction in cancer risk and 
modifications in tumor behavior. A growing body of 
epidemiological and preclinical evidence points to 
culinary herbs and spices as minor dietary constitu-
ents with multiple anticancer characteristics (Paul 
et al., 2010). In the same direction and in a continu-
ing effort to find more potent and selective antican-
cer compounds, we examined the effect of Egyptian 
thyme, juniper and clove essential oils for their anti-
cancer activity against five different human cancer 
cell lines including liver HepG2, breast MCF-7, 
prostate PC3, colon HCT116 and lung A549. The 
most common cancers are lung, colon, liver and 
prostate, whereas breast cancer (23% of all new 
cancer cases) is the second leading cause of death 
in women worldwide and these days in Egypt as 
well. According to the Egyptian National Research 
Institute biostatistics (2011) liver, breast, colon, lung 
and prostate cancers are important public health 
problem, 37% of all new cancer cases in Egypt are 
breast cancer (Elattar, 2003). Chemotherapy for 
cancer, a devastating cancer with increasing world-
wide incidence and mortality rates, is largely inef-
fective. The discovery and development of effective 
chemotherapeutics is urgently needed. In our effort 
to search for local herbal medicines with promising 
activity against cancer, the present work is the first 
step, and aims to use local aromatic plants for the 
discovery of natural, cheap and safe Egyptian drugs 
that will be followed by continuous steps to achieve 
this goal. In this study, the antioxidant activity as 
well as cytotoxicity and in vitro anticancer evaluation 
of the essential oils from thyme, juniper and clove 
have been assessed against five different human can-
cer cell lines (liver HepG2, breast MCF-7, prostate 
PC3, colon HCT116 and lung A549).
2. MATERIALS AND METHODS
2.1. Raw Materials and Chemicals
2.1.1. Plants
Egyptian dry thyme leaves (Thymus vulgaris), dry 
juniper fruits (Juniperus communis) and dry clove 
buds (Syzygium aromaticum) were obtained and 
identified from the department of medicinal and 
aromatic plants, ministry of agriculture, Egypt. The 
aromatic plants have been chosen because of their 
high content in essential oil, they are inexpensive 
and locally available.
2.1.2. Chemicals
Fetal bovine serum (FBS) and L-glutamine, were 
obtained from Gibco Invitrogen Company (Scotland, 
UK). Dulbecco’s modified Eagle’s (DMEM) medium 
was provided by Cambrex (New Jersey, USA). 
Dimethyl sulfoxide (DMSO), doxorubicin, penicillin, 
streptomycin and Sulfo-Rhodamine-B stain (SRB) 
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide) were obtained from Sigma Chemical 
Company (St. Louis, MO, USA). All other chemi-
cals and reagents used in this study were of analytical 
grade and purchased from Sigma-Aldrich chemical 
Co. (St. Louis, MO, USA).
2.2. Isolation of Essential Oils
The essential oils (EOs) of  thyme, juniper 
and clove were extracted according to the hydro- 
distillation method using Clevenger’s apparatus for 
3 hours (Lamaty et al., 1987). The yield of volatile 
oils was weighed and calculated in g·100 g−1 dry plant.
2.2.1. Identifi cation of Essential Oils
2.2.1.1. Gas chromatography (GC)   analysis 
About five μL of each pure volatile oil was used. 
A GC analysis was performed using a Hewlett-
Packard model 5890 equipped with a flame ioniza-
tion detector (FID). A fused silica capillary column 
DB-5 (60 m ×0.32 mm. id) was used. The oven tem-
perature was maintained initially at 50 °C for 5 min., 
and then programmed from 50 to 250 °C at a rate of 
4 °C·min−1. Helium was used as the carrier gas, at 
flow rate of 1.1 mL·min−1. The injector and detector 
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temperatures were 220 and 250 °C, respectively. The 
retention indices (Kovats index) of the separated 
volatile components were calculated using hydro-
carbons (C7-C21, Sigma-Aldrich Co.) as references 
(Adams, 1995).
2.2.1.2. Gas chromatographic-mass  spectrometric 
analysis (GC/MS) The analysis was carried 
out using a coupled gas chromatography Hewlett-
Packard model (5890) / mass spectrometry Hewlett-
Packard-MS (5970). The ionization voltage was 
70 eV, mass range m/z 39-400 a.m.u. The isolated 
peaks were identified by matching with data from 
the library of mass spectra (National Institute of 
Standard and Technology, NIST) and compared 
with those of authentic compounds and published 
data. The quantitative determination was carried out 
based on peak area integration. Identification of 
the GC components also was confirmed with NIST 
mass spectra library data, as well as on comparison 
of their retention indices with those of authentic 
compounds (Adams, 1995).
2.3. Determination of Antioxidant Activity
2.3.1. β-carotene-linoleate scavenging assay
The antioxidant activities of  thyme, juniper 
and clove volatile oils were evaluated using the 
β-carotene-linoleate scavenging assay (Gülçin et al., 
2007). A volume of  0.1 mg β-carotene in 0.2 mL 
chloroform, 10 mg of  linoleic acid and 100 mg of 
Tween-20 were mixed. The solvent was removed 
at 40 °C under vacuum and the resulting mixture 
was diluted with 10 mL of water and mixed well. 
20 mL of oxygenated water were added to this mix-
ture. Four milliliter aliquots were pipetted into dif-
ferent test tubes containing 200 μL of  each volatile 
oil (20, 40, 60 and 80 μg·mL−1) and TBHQ (20, 40, 
60 and 80 μg·mL−1) in ethanol. TBHQ, a standard 
synthetic antioxidant, was used for comparative 
purposes. A control containing 200 μL of  ethanol 
and 4 mL of the above emulsion was prepared. The 
tubes were placed at 50 °C in a water bath and the 
absorbance at 470 nm was taken at time zero (t =0). 
The measurement of  the absorbance continued to 
until the color of  β-carotene disappeared in the 
control tubes (t =60 min) at an interval of  15 min. 
A mixture prepared as mentioned above without 
β-carotene served as a blank. All determinations 
were carried out in triplicate. The antioxidant activ-
ities (A.A.) of  the essential oils were evaluated in 
terms of  bleaching of  β-carotene using the follow-
ing formula:
% of Inhibition = [(AB−AA)/AB] ×100
Where: AB: absorption of blank sample (t =0 min).
AA: absorption of sample solution (t =60 min).
The results were expressed in % basis in preventing 
the bleaching of β-carotene.
2.3.2. DPPH radical scavenging activity assay
Antioxidant activity was also determined by 
2,2-diphenyl-1-picrylhydrazyl (DPPH) assay using 
a spectrophotometer at 517 nm (Gülçin, 2006). 
Each volatile oil of different concentrations (20, 40, 
60 and 80 μg·mL−1) and TBHQ (20, 40, 60 and 
80  μg·mL−1) was collected in different test tubes. 
Four milliliters of 0.1 mM methanolic DPPH were 
added to these tubes and they were shaken vigor-
ously. The tubes were allowed to stand at room 
temperature for 30 min. The control was prepared 
without any extract and methanol. The changes in 
the absorbance of the prepared samples were mea-
sured at 517 nm (Gülçin, 2006). Radical scavenging 
activity was estimated as the inhibition percentage 
and was calculated using the following formula:
% of Inhibition = [(AB−AA)/AB] ×100
Where: AB: absorption of  blank (t =0 min). 
AA: absorption of sample solution (t =30 min).
2.4. Anticancer Activity
2.4.1. Cell lines and culturing
Anticancer activity screening for the thyme, juni-
per and clove volatile oils was carried out and 5 dif-
ferent human cancer cell lines including liver HepG2, 
breast MCF-7, prostate PC3, colon HCT116 and 
lung A549 were obtained from the American 
Type Culture Collection (Rockville, MD, USA). 
The tumor cells were kept in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% 
heat inactivated fetal calf  serum (GIBCO), peni-
cillin (100  U·mL−1) and streptomycin (100 μg·mL) 
at 37  °C in a humidified atmosphere containing 
5% CO2. Cells were grown at a concentration of 
0.50 ×106 were grown in 5 mL of a complete culture 
medium.
2.4.2. In vitro antiproliferative assay
The antiproliferative activity was measured 
in  vitro using the Sulfo-Rhodamine-B stain (SRB) 
assay according to the previously reported stan-
dard procedure (Skehan et al., 1990). Briefly, the 
cells were inoculated in a 96-well microliter plate 
(104 cells/ well) for 24 h before treatment with the 
tested volatile oils to allow the cells to attach to 
the wall of the plate. The thyme, juniper and clove 
volatile oils were dissolved in DMSO and diluted 
with saline to the appropriate volume. Different con-
centrations of the compounds under test and the ref-
erence drug, doxorubicin (0–100 μg·mL−1) were 
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added to the cells. Triplicate wells were prepared 
for each individual dose. Monolayer cells were incu-
bated with the volatile oils for 48 h at 37 °C and in 
an atmosphere of 5% CO2. After 48 h, the cells were 
fixed, washed, and stained for 30 min with 0.4% (w/v) 
SRB dissolved in 1% acetic acid. Unbound dye was 
removed by four washes with 1% acetic acid, and 
the attached stain was recovered with a Tris-EDTA 
buffer. Color intensity was measured in an ELISA 
reader. The relation between the surviving fraction 
and the concentration of volatile oils was plotted 
to get the survival curve for each cell line after the 
specified time. The concentration required for 50% 
inhibition of cell viability (IC50) was calculated and 
the results are given in Table 3.
2.5. Statistical analysis
The results are reported as Mean ± Standard 
Error (S.E.) for the experiments carried out at least 
in triplicate. Statistical differences were analyzed by 
one way ANOVA test.
3. RESULTS AND DISCUSSION
3.1. Total yield and chemical composition of 
essential oils
The total yield of  the essential oil from juni-
per fruits, thyme leaves and clove buds (relative to 
the amount of  dried plant used) was 6.22±0.57, 
4.87±0.33 and 9.32±0.61% (w/w) as shown in 
Figure 1. Our results reveal that the Egyptian aro-
matic plants under investigation are an excellent 
source of  essential oils with relatively high yield 
compared with those cultivated in other coun-
tries. Lee and Shibamoto (2001) reported that the 
total yield of  essential oil from American clove 
buds was 2.73%. The oil yield ranged from 0.70 to 
2.1% of juniper cultivated in Estonia (Orav et al., 
2010) while the yield was 0.99% for Iranian thyme 
(Ghomi et  al., 2009). The results obtained from 
the GC and GC–MS chemical analysis of  thyme, 
juniper and clove EOs are presented in Table 1 and 
Figure 2. In total, 39 compounds were identified. 
Regarding the groups of  chemical constituents rep-
resented, the three essential oils mainly consisted of 
monoterpene hydrocarbons (M), light oxygenated 
compounds (LOC), heavy oxygenated compounds 
(HOC) and sesquiterpene hydrocarbons (S). As 
shown in Figure 1. Light oxygenated compounds 
(LOC) were the major portion of  thyme and clove 
EO samples, while juniper oil was found to be rich 
in monoterpene (M) and sesquiterpene (S) com-
pounds. HOC were the minor portion in all tested 
essential oils, and represent 2.84, 0.33 and 4.83% 
for juniper, thyme and clove respectively. These 
findings are in agreement with the results of  Nikoli, 
et al. (2014), where LOC were the major volatile 
portions of  thyme cultivated in Serbia. Pepeljnjak, 
et al. (2005) reported that the content in essential 
oil in juniper cultivated in Croatia ranges from 
0.5 to 2.50% and its main compounds are terpene 
hydrocarbons such as α- and β-pinene, sabinene 
and thujone, etc. Essential oil also contains ses-
quiterpene hydrocarbons (caryophyllene, cadinene, 
elemene). The chemical composition of  the inves-
tigated essential oils is shown in table 1;twenty-
seven compounds were identified in juniper oil, 
which accounted for 90.84% of the total oil; the 
major constituent was α-pinene (31.19%). Thyme 
and clove oils showed twenty-two and seven com-
pounds, respectively, which accounted for 98.68% 
and 97.93% of the total oil; the main constituent 
was thymol (79.15%) and eugenol (82.71%) for 
thyme and clove, respectively. Our results on the 
chemical profiling of  three Egyptian EOs are in 
agreement with many studies (Orav et al., 2010; 
Teixeira et al., 2013; Nikoli et al., 2014) which 
reported that a GC/MS analysis revealed α-pinene, 
thymol and eugenol as the major components of 
juniper, thyme and clove, respectively. Some other 
previous studies found similar chemical composi-
tions for juniper, clove and thyme essential oils, but 
in different concentrations (Pepeljnjak et al., 2005). 
β-caryophyllene was a common volatile compound 
present in three essential oils, which represent 9.90, 
3.72 and 9.64% in juniper, thyme and clove respec-
tively. Caryophyllenes, including β-caryophyllene, 
α-caryophyllene (α-humulene) and γ-caryophyllene 
(isocaryophyllene) are sesquiterpenes present in var-
ious essential oils. Natural bicyclic β-caryophyllene 
and iso-caryophyllene are trans and cis double 
isomers, respectively, while α-humulene is a ring-
opened isomer.
In essential oils, β-caryophyllene is  frequently found 
mixed with iso-caryophyllene and/or α-humulene. 
Essential oils are widely used in aromatherapy to 
FIGURE 1. Total yield of essential oils (g oil·100 g−1 dry 
weight plant) from Egyptian thyme, juniper and clove.
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TABLE 1. Chemical composition of essential oils.
Peak No. Constituents(a) RI
Type of 
compound
Relative area % Methods of 
identification(b)Clove Thyme Juniper
1 α-Thujene 924 M 0.60 1.90 – RI, MS
2 α-Pinene 930 M 31.19 1.20 – RI, MS & St
3 Camphene 939 M – 0.90 – RI, MS & St
4 Sabinene 961 M 0.80 0.70 – RI, MS & St
5 β-pinene 969 M – 0.40 – RI, MS & St
6 β-Myrcene 989 M 1.18 1.30 – RI, MS
7 α-Phellandrene 1000 M 1.83 – – RI, MS
8 α-Terpinene 1010 M 0.48 0.80 – RI, MS & St
9 p-Cymene 1016 M – 10.33 – RI, MS
10 Limonene 1019 M – 0.60 – RI, MS & St
11 1,8-Cineol 1024 LOC – 1.20 – RI, MS & St
12 Cis-Sabinen hydrate 1070 LOC 0.35 0.22 – RI, MS
13 Linalool 1093 LOC 3.16 0.81 – RI, MS & St
14 Trans-pinocarveol 1130 LOC 0.63 – – RI, MS
15 Camphor 1146 LOC 0.85 – – RI, MS & St
16 Borneol 1158 LOC – 1.76 – RI, MS & St
17 p-Mentha-1,5-dien-8-ol 1162 LOC 0.93 – – RI, MS
18 α-Terpineol 1206 LOC 2.85 2.15 – RI, MS
19 Thymol 1292 LOC – 59.15 – RI, MS & St
20 Carvacrol 1299 LOC – 7.56 – RI, MS & St
21 α-terpinenyl acetate 1321 LOC 1.55 0.17 – RI, MS
22 Neo-menthole 1339 LOC 0.33 – – RI, MS
23 Thymol acetate 1346 LOC – 0.45 – RI, MS
24 Eugenol 1355 LOC – – 82.71 RI, MS & St
25 Carvacrol acetate 1365 LOC – 0.32 – RI, MS
26 Linalyl acetate LOC 2.79 – – RI, MS
27 α-Copaene 1369 S 0.32 – – RI, MS
28 Elemene 1391 S 1.26 – 0.14 RI, MS
29 β-Caryophyllene 1409 S 9.91 3.72 9.64 RI, MS
30 α-Humulene 1449 S 4.83 – 0.51 RI, MS
31 α-Muurolene 1477 S 2.53 – – RI, MS
32 Germacrene-D 1488 S 3.84 – – RI, MS
33 γ-Cubebene S 8.85 – – RI, MS
34 γ-Cadinene 1500 S 1.39 2.31 0.09 RI, MS
35 δ-Cadinene 1515 S 5.58 – – RI, MS
36 Eugenol acetate 1528 HOC – – 4.70 RI, MS
37 Germacrene-B 1556 S 0.91 – – RI, MS
38 (-)-Caryophyllene oxide 1572 HOC 1.35 0.33 0.13 RI, MS
39 Torreyol 1646 HOC 0.58 – – RI, MS
Monoterpenes (M) 36.08% 18.13% 0%
Light Oxygenated Compounds (LOC) 13.44% 73.79% 82.71%
Heavy Oxygenated Compounds (HOC) 2.84% 0.33% 4.83%
Sesquiterpenes (S) 38.51% 6.03% 10.38%
Total Identified % 90.84% 98.00% 97.93%
a: Compound listed in the order of elution from a DB5 column;
RI: Retention indices relative to C7–C20 n-alkanes on the DB-5MS column;
b: Identification based on retention index; MS, identification based on comparison of mass spectra;
- : Absent
6 • M.M. Ramadan, M.M. Ali, K.Z. Ghanem and A.H. El-Ghorabe
Grasas Aceites 66 (2), April–June 2015, e080. ISSN-L: 0017–3495 doi: http://dx.doi.org/10.3989/gya.0955142
alleviate symptoms of stress-induced anxiety; mild 
mood disorders and cancer pain. A number of active 
constituents are thought to be responsible for the 
medicinal action of essential oils. The essential oils 
of aromatic plants contain monoterpene and sesqui-
terpene hydrocarbons (such as limonene, γ-terpinene, 
α- and β-pinene, β-myrcene, sabinene…) and oxygen-
ated derivatives (such as linalool, thymol, carvecrol, 
eugenol…) which play a very important role as anti-
oxidants (Dugo et al., 2000).
3.2. Antioxidative activity
The essential oils were investigated for their 
 radical-scavenging activity. Two different assays were 
conducted in order to evaluate their antioxidant 
properties; scavenging activity on DPPH radicals 
and inhibition of lipid peroxidation in a β-carotene–
linoleate system. The results of the DPPH assay 
are shown in Table. 2. It is evident that all concen-
trations of the tested essential oils (20, 40, 60 and 
80 μg·mL−1) exhibited an excellent anti-oxidative 
potential compared with the standard antioxidant 
TBHQ, especially at their highest concentrations 
(80 μg·mL−1), the thyme, juniper and clove oils 
exhibited inhibitions of 90.12, 85.63 and 93.24%, 
respectively, as shown in Figure 3. The excellent 
antioxidant activity is  attributed to volatile constitu-
ents; these components could change free radicals 
such as DPPH• to non-radical DPPH-H (Ramadan 
et al., 2013a). Numerous and diverse techniques are 
available to evaluate the antioxidant activities of 
specific compounds or complex mixtures such as 
EOs; however a single procedure cannot identify all 
the possible mechanisms characterizing an antioxi-
dant. Therefore, Table 2 also shows the results of the 
β-carotene bleaching assay based on the loss in the 
yellow color of β-carotene due to its reaction with 
radicals produced during linoleic acid oxidation. 
The high inhibition effect of the oxidation of linoleic 
acid and the subsequent bleaching of β-carotene 
compared to TBHQ at the same concentration may 
be attributed to the presence of terpene hydrocar-
bons and oxygenated volatile compounds (Ramadan 
et al., 2013a). In both assays, the radical scaveng-
ing capacity of the tested EOs increased in a con-
centration dependent manner. The volatile extracts 
from some Egyptian spices possess excellent radical 
scavenging activity in DPPH and ABTS scaveng-
ing assays (Ramadan et al., 2013b; Ramadan et al., 
2014). It is well known that oxygenated terpenes 
such as (thymol and eugenol) exhibited a higher 
antioxidant power in comparison to the other iden-
tified classes. Clove oil, rich with eugenol, was the 
superior oil as antioxidant in the DPPH as well as 
in the β-Carotene assay, when compared to the syn-
thetic antioxidant TBHQ as shown in Table 2. The 
 highest concentration (80 μg·mL−1) of thyme, juniper 
and clove oils exhibited very good scavenging activ-
ity and a high level of inhibition of lipid peroxida-
tion in a β-carotene–linoleate system compared with 
TBHQ. The % inhibition values were 84.61, 80.51 
and 91.23%, respectively (Figure 3). The order of 
% inhibition of free radicals offered by the essential 
oils was clove > thyme > juniper. The strong antioxi-
dant profiles of thyme, Juniper and clove oils have 
been proved in several studies. The results obtained 
from this study arein agreement with Lesjak, et al. 
(2011), who reported that juniper extract has shown 
a  significant DPPH scavenger activity, which was 
still notably lower than the synthetic antioxidant 
TABLE 2. Antioxidant activity (A.A.) of essential oils by two different methods.
Inhibition % at different concentrations of essential oils
A.A. by DPPH free radical assay (μg·mL−1) A.A. by β- carotene/ linoleic acid assay (μg·mL−1)
20 40 60 80 20 40 60 80
Thyme 46.77±2.50 68.88±2.10 81.32±3.10 90.12±2.70 40.93±2.20 67.34±1.90 75.98±2.70 84.61±2.70
Juniper 29.14±2.10 48.12±1.70 64.22±3.90 85.63±4.10 38.97±1.50 57.94±1.70 78.99±2.00 80.51±2.70
Clove 59.11±2.60 69.28±3.10 84.25±3.30 93.24±3.90 54.13±1.90 77.54±2.90 85.88±2.90 91.23±3.50
TBHQ 61.13±1.80 72.15±2.30 86.96±2.60 96.00±2.20 58.33±2.00 74.00±1.80 88.27±3.10 94.78±3.30
TBHQ: Tert –butyl hydroquinone, standard synthetic antioxidant.
Each value represents the mean ± S.E (Standard Error) of three repeated experiments.
FIGURE 2. Relative area % of groups of chemical constituents 
of essential oils. The chemical constituents are monoterpene 
hydrocarbons (M), light oxygenated compounds (LOC), 
heavy oxygenated compounds (HOC) and sesquiterpene 
hydrocarbons (S).
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TBHQ. Gülçin, et al. (2012) reported that the DPPH 
free radical scavenging activity of clove oil increased 
with an increasing concentration of clove oil. The 
antioxidant activities of the basic components of 
the essential oils of thyme (carvacrol and thymol) 
have been demonstrated (Jordan et al., 2013). The 
study of some antioxidants used in cancer treatment 
is a rapidly improving area. Antioxidants have been 
extensively studied for their ability to prevent or treat 
cancer in humans. Also, a regular intake of natural 
antioxidants is associated with reduced risks of can-
cer. The antioxidant activity exhibited by the tested 
EOs justifies traditional uses of Egyptian herbs. The 
observed antioxidant potential should be attributed 
to the phenolic oil constituents, while the oil chemo-
protective efficacy against oxidative stress-mediated 
disorders is mainly due to its free radical scaveng-
ing properties. Recent studies have demonstrated 
that α-pinene (2,6,6-tri-methyl-bicyclo [3.1.1] hept-
2-ene), the main component in Egyptian juniper, is 
present naturally in the essential oils of many aro-
matic plants and has antioxidant properties accord-
ing to DPPH radical, hydroxyl radical, superoxide 
anion, malonaldehyde and β-carotene bleaching 
methods (Aydin et al., 2013). α-pinene was reported 
tohave a broad spectrum of biological activities, 
i.e. antioxidant and anticancer activities (Wang 
et al., 2012). Plant extracts, especially volatiles and 
phenolic extracts, as natural antioxidant, showed 
suppressing action against proliferation of human 
cancer cells. The degrees of anti-proliferation were 
time and dose-dependent.
3.3. In vitro antiproliferative and cytotoxic activity
The antiproliferative activities of the Egyptian 
thyme, juniper and clove essential oils were evaluated 
against 5 different human cancer cell lines including 
liver HepG2, breast MCF-7, prostate PC3, colon 
HCT116 and lung A549 using an SRB assay, in 
comparison with doxorubicin as the reference drug. 
The antiproliferative activities were expressed by 
median growth inhibitory concentration (IC50) and 
 provided in Table 3. From the results it is evident that 
although thyme oil displayed potent growth inhibi-
tory activity against MCF-7, PC3, HCT116 and 
A549, it had no activity against the HepG2 cell line. 
The thyme oil exerted antiproliferative activity with 
IC50 values of 22.60±3.00, 23.00±4.20, 24.60±2.60 
and 22.90±3.30 μg·mL−1 in MCF-7, PC3, HCT116 
and A549 respectively. It is clear that, while thyme oil 
had an antiproliferative effect in PC3 and HCT116 
cell lines closed to the doxorubicin, it was more effec-
tive than the doxorubicin in MCF-7 and A549 cell 
lines. For juniper oil, the results revealed that juniper 
oil shows potent growth inhibitory activity against 
HepG2, MCF-7 and A549 cell lines with no activ-
ity against PC3 and HCT116 cell lines. The IC50 was 
18.00±2.40, 22.80±3.50 and 21.75±2.80 μg·mL−1 in 
HepG2, MCF-7 and A549 cell lines, respectively. It 
is clear that the antiproliferative effect of juniper oil 
was more potent than the doxorubicin in HepG2, 
MCF-7 and A549 cell lines. For clove oil the result 
revealed that while treatment with clove oil had no 
effect on HepG2 or MCF-7 cell lines, the IC50 was 
24.00±3.90, 19.00±2.25 and 21.80±3.75 μg·mL−1 
in PC3, HCT116 and A549 cell lines, respectively. 
It is clear that the antiproliferative effect of clove 
oil was similarly potent to the doxorubicin in PC3, 
HCT116 and A549 cell lines. The abundance of 
various components in each essential oil, compris-
ing a complex mixture of mono and sesquiterpenes, 
accounts for the cytotoxic activity of each essential 
oil. The investigation of tumor growth inhibitors 
is a major obstacle in the medical field. For these 
reasons, the development of novel anticancer drugs 
TABLE 3. Cytotoxicity of Egyptian thyme, juniper and cloves essential oils against different types of human malignant cell lines.
Compound
IC50 (μg·mL
−1)
HepG2 MCF-7 PC3 HCT116 A549
Doxorubicin 20.10±2.00 24.00±2.50 18.00±2.00 19.25±2.00 25.50±2.70
Thyme oil NA 22.60±3.00 23.00±4.20 24.60±2.66 22.90±3.30
Juniper oil 18.00±2.40 22.80±3.50 NA NA 21.75±2.80
Cloves oil NA NA 24.00±3.90 19.00±2.25 21.80±3.75
Data are expressed as means ± S.E. of four separate experiments.
NA is no activity.
FIGURE 3. Antioxidant activity of essential oils at 
(80 μg·mL−1) in DPPH and β-carotene bleaching assays.
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is still necessary and is in high demand. This work 
is an attempt to examine the essential oils for their 
cytotoxicity activity against five human cancer 
cell lines. The results revealed that the Egyptian 
essential oils under investigation possessed sig-
nificant anticancer activity. The presence of  many 
volatile compounds that possess antioxidant activ-
ity may be responsible for enhancing the antioxi-
dant activity in vitro as well as protecting human 
organs through the scavenging free radicals (Abd-
Algader et al., 2013). β-Caryophyllene, which is a 
common volatile component of  all tested essential 
oils, has been reported to potentiate the antican-
cer activity of  many tumor cell lines (Rosato et al., 
2008). The anti-oxidative activity of  natural com-
pounds is frequently accompanied by cytoprotec-
tion. Nevertheless, comparative evaluation of  the 
cytotoxicity and the anti-oxidative activity of  the 
oil of  cloves (Syzygium aromaticum) and its com-
ponents (generally recognized as safe) showed that 
this type of  oil and its major component eugenol 
were highly cytotoxic against human fibroblasts 
and endothelial cells even at low concentrations 
(Prashar et al., 2006). Our results showed that 
Egyptian clove oil, which contain 82.71% eugenol 
was similarly potent to the doxorubicin drug in 
PC3, HCT116 and A549 cell lines. The reason for 
the cytotoxicity of  eugenol is probably the induc-
tion of  apoptosis. It is interesting to examine the 
findings of  Pisano et al. (2007), who demonstrated 
that dimeric forms (biphenyls) of  eugenol elicited 
specific antiproliferative and pro-apoptotic activity 
on neuroectodermal tumor cells, possibly indicat-
ing their anticancer effect. Eugenol showed cyto-
toxic effects and acted as a genotoxicant in VH10 
human fibroblasts and in Caco-2 human colonic 
cells, but not in HepG2 human hepatoma cells. 
Until now, various authors have reported on the 
antitumor activities of  EOs and their constitu-
ents. Our results revealed that thyme oil had an 
anti-proliferative effect in PC3 and HCT116 cell 
lines closed to the doxorubicin; it was more effec-
tive than the doxorubicin in MCF-7 and A549 cell 
lines. According to AitM’barek et al. (2007), the 
thyme oil, which contains thymol as its major con-
stituent, has an important in vitro cytotoxic activ-
ity against tumor cells. Our thyme EO inhibited 
the viability of  several tumor cell lines. The activ-
ity of  the oil is frequently attributed to the specific 
oil constituents, Tsukamoto et al. (1989) reported 
that thymol, which is the major constituent in our 
EO, might be involved in the stimulation of  the 
active proliferation of  pulp fibroblasts. Whether 
the thymol alone, or in combination with other 
oil constituents is responsible for the observed 
cytotoxicity against tumor cells still remains to be 
revealed, and presents an important limitation of 
the study. Strong antioxidant and antitumor activ-
ity supports the traditional use of  thyme, which 
showed the strongest biological activity. In addi-
tion to their use in food and cosmetics, the thyme 
oil represents a great potential in anti-cancer treat-
ments and certainly deserves further study (Nikoli 
et al., 2014). The antitumor activities of  juniper 
oil and its constituents showed good and moder-
ate levels of  tumor inhibition. Our results showed 
that Egyptian juniper oil, which contains 26.19% 
α-pinene, was more potent than the doxorubi-
cin drug in HepG2, MCF-7 and A549 cell lines. 
Wang et al. (2012) has mentioned that α-pinene 
demonstrated strong cytotoxicity towards human 
ovarian cancer cell lines (SK-OV-3 and HO-8910) 
and the human hepatocellular liver carcinoma cell 
line (Bel-7402). Also, Matsuo et al. (2011) revealed 
that α-pinene was able to induce apoptosis evi-
denced by early disruption of  the mitochondrial 
potential and production of  reactive oxygen spe-
cies. The exact mechanisms of  the cytotoxic action 
of  α-pinene are not known, but oxidative stress 
is thought to be the main responsible mecha-
nism in its cellular toxicity. In addition to oxida-
tive stress, previous studies reported that different 
mechanisms have been linked to plant products’ 
cytotoxicity, including: (i) proteasome inhibition; 
(ii) topoisomerase inhibition; (iii) inhibition of 
fatty acid synthesis; (iv) accumulation of  p53; (v) 
induction of  cell cycle arrest; (vi) inhibition of 
phosphatidyl-inositol 3-kinase; or (vii) enhanced 
expression of  c-fos and c-myc (Brusselmans et al., 
2005). Aydin et al. (2013) indicated that α-pinene is 
neither genotoxic nor mutagenic on healthy neu-
rons or N2a NB cells and demonstrates that pure 
α-pinene possesses weak antioxidant and cytotoxic 
activity in cultured primary rat neurons. In addi-
tion, pure α-pinene has weak antioxidant proper-
ties and little anticancer potential on rat N2a NB 
cell line and suggests that α-pinene is of  a limited 
therapeutic use as an anticancer agent. This may 
be revealed in the importance of  synergism among 
all the components in essential oil. Our results in 
Table 1 showed that, beside the main volatile com-
ponent of  Egyptian juniper (α-pinene), there were 
other considerable amounts of  volatile antioxi-
dants such as, β-caryophyllene (9.91%), γ-Cubebene 
(8.85%), δ-Cadinene (5.58%), α-Humulene (4.83%), 
D-Germacrene (3.84%), Linalool (3.16%), α-
Muurolene (2.53%), α-Terpineol (2.85%) as well as 
other minor constituents which together may have 
a synergistic effect. Thus, the oil is more effective 
than its pure, main component.
4. CONCLUSIONS
To summarize, we concluded that Egyptian 
thyme, juniper and clove essential oils are poten-
tial candidates for further development as an adju-
vant in the modern chemotherapeutic treatment of 
 different types of cancers.
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